Skip to main content
. 2013 Apr 30;108(10):1925–1930. doi: 10.1038/bjc.2013.192

Table 1. Synopsis of results of published studies investigating the potential of circulating miRNAs as biomarkers of prostate cancer.

Study design Upregulated miRNAs Downregulated miRNAs Sample type Method Patient numbers Reference
Cancer vs benign
100, 125b, 141, 143, 296
 
Serum
qRT-PCR
25 metastatic PCa vs 25 controls
Mitchell et al, 2008
 
16, 92a, 103, 107, 197, 34b, 328, 485-3p, 486-5p, 92b, 574-3p, 636, 640, 766, 885-5p
 
Serum
MiR microarray
5 PCa vs 8 controls (other cancers tested)
Lodes et al, 2009
 
221
 
Plasma
qRT-PCR
28 PCa vs 20 controls
Zheng et al, 2011
 
141, 298, 346, 375
 
Serum
qRT-PCR
25 metastatic PCa vs 25 controls
Selth et al, 2012
 
346, 622, 940, 1285
let-7e, let-7c
Plasma
Illumina miR microarray
25 PCa vs 17 BPH, then validation in 80 PCa, 44 BPH and 54 HI
Chen et al, 2012
 
375, 141
181a-2
Plasma
qRT-PCR
78 PCa vs 28 controls, then 16 metastatic vs 55 non-metastatic
Bryant et al, 2012
Localised cancer vs metastatic cancer
9*, 141, 200b, 375, 516a
 
Serum
qRT-PCR
7 metastatic PCa vs 14 localised PCa
Brase et al, 2011
 
21
 
Serum
qRT-PCR
50 PCa (20 localised, 20 ADPC, 10 HRPC) vs 6 BPH
Zhang et al, 2011
 
375, 141
181a-2
Plasma
qRT-PCR
78 PCa vs 28 controls, then 16 metastatic vs 55 non-metastatic
Bryant et al, 2012
Cancer at different stage/risks vs benign
21, 221
 
Plasma
qRT-PCR
51 PCa (18 localised, 8 locally advanced, 25 metastatic) vs 20 HI
Yaman Agaoglu et al, 2011
 
93, 106a, 874, 1207
24, 26b, 30c, 223
Serum
Multiplexed qRT-PCR
36 PCa (12 low risk, 12 medium risk, 12 high risk) vs 12 controls
Moltzahn et al, 2011
 
26a, 195, Let7i, 16
 
Serum
qRT-PCR
45 (37 localised, 8 metastatic) PCa vs 38 controls (18 BPH, 20 HI)
Mahn et al, 2011
  20a, 21   Plasma qRT-PCR 82 PCa assessing association with CAPRA score Shen et al, 2012

Abbreviations: ADPC=androgen-dependent prostate cancer; HRPC=hormone refractory prostate cancer; BPH=benign prostatic hypertrophy; HI= healthy individuals; PCa=prostate cancer; qRT-PCR=quantitative real-time PCR; miR=microRNA; CAPRA=Cancer of the Prostate Risk Assessment. *Where one hairpin miR precursor gives rise to two mature miRs, one from each arm, an asterisk is used to denote the least predominant form.